Mateo, J. (José)

Filtering

2018 - 201912020 - 20211

Settings

Author search.filters.isAuthorOfPublication.1b0e1a5f-2043-43ee-ad6c-48f287a015d2

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Cancer-associated thrombosis: Beyond clinical practice guidelines-A multidisciplinary (SEMI-SEOM-SETH) expert consensus
    (Thieme, 2018) Muñoz, A. (Andrés); Perez-Segura, P. (Pedro); Font, C. (C.); Gallardo, E. (Enrique); Maestre, A. (Ana); Trujillo-Santos, J. (Javier); Pachón, V. (Vanessa); Mateo, J. (José); Peris, M.L. (María Luisa); Gonzalez-Porras, J.R. (José Ramón); Domènech, P. (Pere); Lecumberri, R. (Ramón)
    Despite the growing interest and improved knowledge about venous thromboembolism in cancer patients in the last years, there are still many unsolved issues. Due to the limitations of the available literature, evidence-based clinical practice guidelines are not able to give solid recommendations for challenging scenarios often present in the setting of cancer-associated thrombosis (CAT). A multidisciplinary expert panel from three scientific societies—Spanish Society of Internal Medicine (SEMI), Spanish Society of Medical Oncology (SEOM), and Spanish Society Thrombosis and Haemostasis (SETH) —agreed on 12 controversial questions regarding prevention and management of CAT, which were thoroughly reviewed to provide further guidance. The suggestions presented herein may facilitate clinical decisions in specific complex circumstances, until these can be made leaning on reliable scientific evidence.
  • Thumbnail Image
    Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology
    (Elsevier, 2021) Castelo-Branco, L.; Awada, A. (Ahmad); Pentheroudakis, (G. E. ) George E.; Perez-Gracia, J.L. (Jose Luis); Mateo, J. (José); Curigliano, G. (Giuseppe); Banerjee, S. (S.); Giuliani, R. (Rosa); Lordick, F. (F.); Cervantes, A. (Andrés); Tabernero, J. (J.); Peters, S. (S.)
    Since the beginning of 2020, the coronavirus disease 2019 (COVID-19) pandemic has progressively affected millions of people worldwide and has brought many uncertainties for patients, health professionals, and policymakers. According to the World Health Organization (WHO), as of 3 June 2021, there were 171 222 477 confirmed cases of COVID-19, including 3 686 142 deaths. Published evidence consistently shows that cancer patients are at a higher risk of death from COVID-19.2-4 In the first months of the pandemic, all levels of care (screening, diagnosis, treatment, and follow-up) were disrupted.5-7 Moreover, cancer centers started prioritizing care services, cancelling nonurgent appointments, adapting treatment protocols, and shifting to home-based remote care relying on telemedicine consultations.5,7 The deferral of screening programs and cancer-directed interventions generates concerns for an increase in the number of patients diagnosed with advanced disease stage and poor outcomes.